Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Glucagon receptor antagonist-11

Glucagon receptor antagonist-11 (Compound 14) is a glucagon receptor antagonist with a pIC50 of 6.677. Glucagon receptor antagonist-10 can be used in studies of glucose homeostasis[1].

Product Specifications

CAS Number

152121-19-2

UNSPSC

12352005

Target

GCGR

Related Pathways

GPCR/G Protein

Field of Research

Metabolic Disease

Smiles

N#CC1=CC=C(C2=NC(C3=CC=NC=C3)=C(C4=CC=C(F)C=C4)N2)C=C1

Molecular Formula

C21H13FN4

Molecular Weight

340.35

References & Citations

[1]Shahlaei M, et al. Prediction of glucagon receptor antagonist activities of some substituted imidazoles using combined radial basis function neural network and density functional theory. Medicinal Chemistry Research, 2014, 23 (6) : 2744-2756.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

ARF5 (NM_001662) Human Over-expression Lysate
LY400628 100 µg

ARF5 (NM_001662) Human Over-expression Lysate

Sign In for Pricing
View Details
SLC7A5P2 Human qPCR Primer Pair (NM_199182)
HP219483 200 Reactions

SLC7A5P2 Human qPCR Primer Pair (NM_199182)

Sign In for Pricing
View Details
TOR1AIP1 (NM_015602) Human Recombinant Protein
TP321686M 100 µg

TOR1AIP1 (NM_015602) Human Recombinant Protein

Sign In for Pricing
View Details
Mix-n-StainTM CF®790 Antibody Labeling Kit, 1x (20-50ug) labeling
#92268 1 Kit

Mix-n-StainTM CF®790 Antibody Labeling Kit, 1x (20-50ug) labeling

Sign In for Pricing
View Details
JAK2 (Ab-1007) Antibody
8B7126-AAT 50 µg

JAK2 (Ab-1007) Antibody

Sign In for Pricing
View Details
ERCC1 / RAD10 (Tumor Progression Marker) (ERCC1/2683), CF647 conjugate, 0.1mg/mL
BNC472683-100 1x 100 µL

ERCC1 / RAD10 (Tumor Progression Marker) (ERCC1/2683), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details